Partnering-with-google-in-quantum-computing Partnering-with-google-in-quantum-computing New cooperation with Google explores the potentials of quantum computing for pharma R&D.
founding-member-of-QUTAC founding-member-of-QUTAC Together, the members of this newly founded consortium want to explore industrial applications for quantum computing
Women in STEM 2022 Women in STEM 2022 Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM.
Data science, agile working, UX design: our evolving IT careers Data science, agile working, UX design: our evolving IT careers Meet our IT colleagues working in the fields of user experience, data science and agile development
Boehringer-Ingelheim's-half-year-figures-2021 Boehringer-Ingelheim's-half-year-figures-2021 Press release on Boehringer Ingelheim's half-year figures 2021. Business development from January to June 2021.
Who are we? Who are we? Started in 1885 by Albert Boehringer, this independent family-owned company has grown into a top contributor in Human Pharma and Animal Health.
Partnership with IBM to accelerate new antibody therapies Partnership with IBM to accelerate new antibody therapies Boehringer Ingelheim collaborates with IBM to advance generative AI and foundation models for therapeutic antibody development
global-top-employer global-top-employer For the first time, Boehringer Ingelheim receives the award as a Global Top Employer as well as individual awards in 27 countries.
collaboration-Yale collaboration-Yale Yale-Boehringer Ingelheim Biomedical Data Science Fellowship Program Seeks to Attract Top Researchers from Around the World
Retinal Health: Meet the Scientists Retinal Health: Meet the Scientists We aim to prevent, treat, and restore vision loss. Delve behind the lab to see our scientists spearheading research to address retinopathies.
Genomic Lens Linking Worlds in DNA Genomic Lens Linking Worlds in DNA Adding a new dimension to drug discovery with the help of data science and DNA
Partnership Boehringer Ingelheim Lifebit health data Partnership Boehringer Ingelheim Lifebit health data Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data
Jens Barthelmes Jens Barthelmes My career challenge at Boehringer Ingelheim by Jens Barthelmes. Read it now!
Combating complex diseases with data Combating complex diseases with data How does big data create disrupting insights for our company? Read about potential use cases and promoting a data mindset
Technologies Technologies We are expanding our global network of technology partners Learn more about partnering with us.
Behind the Lab Behind the Lab Delve behind the lab to see how our Retinal Health scientists are spearheading research into novel therapeutics to treat retinopathies.
Really Digital, Mr Hach! Really Digital, Mr Hach! The Head of User Experience and SCRUM at Boehringer Ingelheim’s digital lab BI X offers a glimpse into his work and motivation.
Early careers Early careers At Boehringer Ingelheim, we know how important it is to lay the right foundations in your career and build on them with care and support.
AI&Data Science Fellowship Tuebingen AI&Data Science Fellowship Tuebingen AI&Data Science Fellowship Tuebingen
Large Scale Cell Culture Facility | Bioxcellence | Boehringer Ingelheim Large Scale Cell Culture Facility | Bioxcellence | Boehringer Ingelheim Tour our Large Scale Cell Culture Facility in Vienna, Austria, advancing biopharmaceutical production with cutting-edge cell culture technology.
Feline diabetes: how to detect and treat it Feline diabetes: how to detect and treat it What are the symptoms of diabetes in cats, and how do you manage this chronic disease? Find the answers here.
Innovation in medicinal chemistry Innovation in medicinal chemistry Darryl McConnell, Research Site Head, Austria and Jürgen Mack, Medicinal Chemistry, explain how we are working to unlock unsolved diseases